LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.13
EUR
0.00
EUR
0.09 %
22.04.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 2.55 USD | 0.04 USD | 1.46 % |
|---|
| Vortag | 2.51 USD | Datum | 20.04.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 86.41% | |
| 21shares Morpho ETP | CH1506167027 | 71.75% | |
| 21Shares Bittensor ETP | CH1495416971 | 1.20% | |
| 21shares Canton Network ETP | CH1503127917 | 1.02% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | -4.14% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -10.50% | |
| 21Shares Jupiter ETP | CH1480821383 | -14.02% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -23.77% | |
| 21Shares Dogecoin ETP | CH1431521033 | -25.21% | |
| 21Shares XDC Network ETP | CH1464217285 | -25.67% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 5.73% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | -0.40% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | -12.00% | |
| 21Shares Artificial Superintelligence Alliance ETP | CH1480821375 | -22.67% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -32.23% | |
| 21Shares XDC Network ETP | CH1464217285 | -53.24% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -53.63% | |
| 21Shares Dogecoin ETP | CH1431521033 | -53.79% | |
| 21Shares Jupiter ETP | CH1480821383 | -53.81% | |
| 21Shares Injective Staking ETP | CH1360612134 | -64.08% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | 48.77% | |
| 21Shares Ethereum Staking ETP | CH0454664027 | 47.55% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | 31.99% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 25.13% | |
| 21Shares Binance BNB ETP | CH0496454155 | 5.27% | |
| 21Shares Dogecoin ETP | CH1431521033 | -39.81% | |
| 21Shares Sui Staking ETP | CH1360612159 | -54.77% | |
| 21Shares Immutable ETP | CH1360612142 | -57.35% | |
| 21Shares Injective Staking ETP | CH1360612134 | -57.91% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 173.79% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 73.17% | |
| 21Shares Stellar ETP | CH1109575535 | 50.86% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 43.82% | |
| 21Shares Aave ETP | CH1135202120 | 28.06% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 570’617.98 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 22.04.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 49.80 | |
| Performance 2 Jahre | 30.70 | |
| Performance 3 Jahre | -0.71 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |